146 related articles for article (PubMed ID: 38697444)
1. Functionalized liposomes as a potential drug delivery systems for colon cancer treatment: A systematic review.
Moghimipour E; Handali S
Int J Biol Macromol; 2024 Jun; 269(Pt 1):132023. PubMed ID: 38697444
[TBL] [Abstract][Full Text] [Related]
2. Functionalized liposomes as drug nanocarriers for active targeted cancer therapy: a systematic review.
Abbasi H; Rahbar N; Kouchak M; Khalil Dezfuli P; Handali S
J Liposome Res; 2022 Jun; 32(2):195-210. PubMed ID: 33729077
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
[TBL] [Abstract][Full Text] [Related]
4. Liposomes, new carriers for delivery of genes and anticancer drugs: a systematic review.
Salari N; Rasoulpoor S; Valipour E; Mansouri K; Bartina Y; Dokaneheifard S; Mohammadi M; Abam F
Anticancer Drugs; 2022 Jan; 33(1):e9-e20. PubMed ID: 34282743
[TBL] [Abstract][Full Text] [Related]
5. Development of liposomes entrapped in alginate beads for the treatment of colorectal cancer.
Bansal D; Gulbake A; Tiwari J; Jain SK
Int J Biol Macromol; 2016 Jan; 82():687-95. PubMed ID: 26464131
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in liposome-based targeted cancer therapy.
Fidan Y; Muçaj S; Timur SS; Gürsoy RN
J Liposome Res; 2024 Jun; 34(2):316-334. PubMed ID: 37814217
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-functionalized liposomes for targeted cancer therapy.
Moosavian SA; Sahebkar A
Cancer Lett; 2019 Apr; 448():144-154. PubMed ID: 30763718
[TBL] [Abstract][Full Text] [Related]
8. A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Kouchak M; Amini M; Angali KA; Saremy S; Dorkoosh FA
Biomed Pharmacother; 2018 Dec; 108():1259-1273. PubMed ID: 30372827
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Efficacy of Artemisinin Loaded in Transferrin-Conjugated Liposomes versus Stealth Liposomes against HCT-8 Colon Cancer Cells.
Leto I; Coronnello M; Righeschi C; Bergonzi MC; Mini E; Bilia AR
ChemMedChem; 2016 Aug; 11(16):1745-51. PubMed ID: 26999297
[TBL] [Abstract][Full Text] [Related]
10. Liposomes: An Emerging Approach for the Treatment of Cancer.
Mishra K; Jain AK
Curr Pharm Des; 2021; 27(20):2398-2414. PubMed ID: 33823772
[TBL] [Abstract][Full Text] [Related]
11. Updates on the use of liposomes for active tumor targeting in cancer therapy.
Yan W; Leung SS; To KK
Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer.
Jinka S; Rachamalla HK; Bhattacharyya T; Sridharan K; Sekhar Jaggarapu MMC; Yakati V; Banerjee R
Biomed Mater; 2021 Feb; 16(2):024105. PubMed ID: 33434900
[TBL] [Abstract][Full Text] [Related]
13. Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release.
Nguyen VD; Zheng S; Han J; Le VH; Park JO; Park S
Colloids Surf B Biointerfaces; 2017 Jun; 154():104-114. PubMed ID: 28329728
[TBL] [Abstract][Full Text] [Related]
14. Active tumor targeting of nanomaterials using folic acid, transferrin and integrin receptors.
Kolhatkar R; Lote A; Khambati H
Curr Drug Discov Technol; 2011 Sep; 8(3):197-206. PubMed ID: 21696360
[TBL] [Abstract][Full Text] [Related]
15. Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer.
Yang Y; Zhao Z; Xie C; Zhao Y
Chem Phys Lipids; 2020 May; 228():104882. PubMed ID: 32017901
[TBL] [Abstract][Full Text] [Related]
16. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
[TBL] [Abstract][Full Text] [Related]
17. Colon Targeted Liposomal Systems (CTLS): Theranostic Potential.
Jain A; Jain SK
Curr Mol Med; 2015; 15(7):621-33. PubMed ID: 26321756
[TBL] [Abstract][Full Text] [Related]
18. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
20. Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy.
Kang XJ; Wang HY; Peng HG; Chen BF; Zhang WY; Wu AH; Xu Q; Huang YZ
Acta Pharmacol Sin; 2017 Jun; 38(6):885-896. PubMed ID: 28479604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
